CLINUVEL PHARMACEUTICALS (ASX:CUV) Updates on CUV105 Case Reports
CLINUVEL Pharmaceuticals highlights positive findings in vitiligo treatment from the CUV105 study with SCENESSE® therapy.

CLINUVEL Pharmaceuticals highlights positive findings in vitiligo treatment from the CUV105 study with SCENESSE® therapy.
Invex Therapeutics secures £114k R&D tax rebate from UK government, aiding its focus on neurological drug development.
RLF AgTech Ltd announces a significant reduction in debt, successful equity raising, and expansion plans in Australia and China.
EBR Systems’ WiSE technology has been accepted into the CMS TCET pathway, allowing expedited Medicare coverage.
Kinatico Limited (ASX:KYP) reported strong revenue growth in H1 FY25, highlighting its successful SaaS strategy and cash accretive position.
EBR Systems reports a successful FDA inspection, expecting approval by April 2025.
Australian Ethical (ASX:AEF) reports record FUM of $13.26 billion, driven by strong investment performance and positive net flows.
PolyNovo Limited (ASX:PNV) reports a strong 22.8% revenue increase in 1H FY25, with significant growth in the US and worldwide sales.
Emmerson Resources Limited announces expanded drilling at White Devil Gold Project with upcoming resource estimates and assay results.
Ardea Resources updates on the DFS for its Kalgoorlie Nickel Project, showcasing drilling progress and team recruitment efforts.